Minoryx Therapeutics, S.L.   Report issue

For profit Phase 3
Founded: Barcelona Spain (2011)

Organization Overview

First Clinical Trial
2017
NCT03231878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Minoryx Therapeutics, S.L.